Hilt Dana Charles Insider Trades

Insider Trading History

Track insider trading activity for Hilt Dana Charles. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Frequency Therapeutics
Frequency Therapeutics FREQ
Chief Medical Officer
Holding Value $8.99k 30,000 shares
Last Trade
Apr 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.30
Frequency Therapeutics
Frequency Therapeutics FREQ
Chief Medical Officer
Holding Value $21k 70,000 shares
Last Trade
Jan 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.30
Frequency Therapeutics
Frequency Therapeutics FREQ
Chief Medical Officer
Holding Value $15k 50,000 shares
Last Trade
Feb 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.30
Frequency Therapeutics
Frequency Therapeutics FREQ
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Oct 02, 2019 Sale
No data
No data
$0.30
Cortexyme
Cortexyme CRTX
SVP Of Clinical Develop. & CMO
Holding Value $52.1k 26,700 shares
Last Trade
Dec 27, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.95
Cortexyme
Cortexyme CRTX
SVP Of Clinical Develop. & CMO
Holding Value $97.5k 50,000 shares
Last Trade
Jun 25, 2006 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.95
Cortexyme
Cortexyme CRTX
SVP Of Clinical Develop. & CMO
Holding Value $0 0 shares
Last Trade
Apr 26, 2006 Sale
No data
No data
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up